EMMI, GIACOMO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 22.749
EU - Europa 16.627
AS - Asia 12.583
SA - Sud America 2.266
Continente sconosciuto - Info sul continente non disponibili 557
AF - Africa 385
OC - Oceania 154
Totale 55.321
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 22.252
RU - Federazione Russa 5.871
IT - Italia 4.030
SG - Singapore 3.334
CN - Cina 3.222
PL - Polonia 1.956
BR - Brasile 1.802
HK - Hong Kong 1.751
VN - Vietnam 1.379
IE - Irlanda 1.213
KR - Corea 1.068
SE - Svezia 811
FR - Francia 637
DE - Germania 509
FI - Finlandia 493
IN - India 452
BD - Bangladesh 330
GB - Regno Unito 311
CA - Canada 292
JO - Giordania 227
CH - Svizzera 202
ID - Indonesia 193
AR - Argentina 174
AU - Australia 149
NL - Olanda 132
JP - Giappone 126
ES - Italia 115
MX - Messico 93
TR - Turchia 90
EC - Ecuador 82
IQ - Iraq 79
AT - Austria 77
ZA - Sudafrica 74
UA - Ucraina 69
CI - Costa d'Avorio 62
MA - Marocco 58
CO - Colombia 52
PK - Pakistan 41
EG - Egitto 38
VE - Venezuela 37
NG - Nigeria 34
PY - Paraguay 34
SA - Arabia Saudita 34
PE - Perù 31
BE - Belgio 30
DZ - Algeria 26
CL - Cile 25
JM - Giamaica 23
KE - Kenya 23
UZ - Uzbekistan 23
TN - Tunisia 22
PH - Filippine 20
AE - Emirati Arabi Uniti 18
BJ - Benin 18
CZ - Repubblica Ceca 17
AZ - Azerbaigian 16
BG - Bulgaria 16
CR - Costa Rica 16
IR - Iran 16
MY - Malesia 16
DK - Danimarca 15
LT - Lituania 15
SK - Slovacchia (Repubblica Slovacca) 15
TH - Thailandia 15
NP - Nepal 14
GR - Grecia 13
KZ - Kazakistan 13
AL - Albania 12
BO - Bolivia 12
IL - Israele 12
UY - Uruguay 12
GT - Guatemala 11
HN - Honduras 11
RO - Romania 11
TW - Taiwan 11
PS - Palestinian Territory 10
HU - Ungheria 9
KG - Kirghizistan 9
AM - Armenia 8
DO - Repubblica Dominicana 8
OM - Oman 8
PA - Panama 7
SV - El Salvador 7
TT - Trinidad e Tobago 7
KH - Cambogia 6
RS - Serbia 6
SN - Senegal 6
BB - Barbados 5
GE - Georgia 5
HR - Croazia 5
LB - Libano 5
MD - Moldavia 5
NO - Norvegia 5
NZ - Nuova Zelanda 5
PR - Porto Rico 5
PT - Portogallo 5
QA - Qatar 5
ET - Etiopia 4
KW - Kuwait 4
LA - Repubblica Popolare Democratica del Laos 4
Totale 54.686
Salva come PNG Salva come JPEG
Città #
Santa Clara 5.112
Ashburn 3.087
Singapore 2.374
Warsaw 1.940
Fairfield 1.509
Hong Kong 1.490
Dublin 1.210
Seoul 1.060
Chandler 850
San Jose 839
Milan 771
Hefei 757
Woodbridge 648
Beijing 605
Seattle 598
Houston 552
Cambridge 509
Ho Chi Minh City 462
Council Bluffs 432
Wilmington 423
Florence 405
Lawrence 403
Los Angeles 394
Moscow 383
Buffalo 357
Altamura 356
Rome 342
The Dalles 324
Hanoi 310
New York 303
Lauterbourg 288
Helsinki 282
Princeton 280
Dallas 256
Boston 243
Mumbai 239
Munich 229
Paris 223
Ann Arbor 213
Bern 175
São Paulo 163
Shanghai 158
Melbourne 138
Jakarta 135
Kent 131
San Diego 122
Boardman 114
Medford 99
Orem 98
Turku 93
Tokyo 90
Clifton 88
Chicago 85
Naples 85
Frankfurt am Main 78
Turin 78
Lappeenranta 74
Guangzhou 71
London 70
Bologna 66
Vienna 66
Da Nang 65
Montreal 65
Chennai 64
Abidjan 62
Toronto 61
Redondo Beach 59
Rio de Janeiro 57
Dong Ket 56
Norwalk 56
Palermo 54
Brooklyn 53
Falls Church 53
Bari 52
Phoenix 51
Haiphong 48
Barcelona 46
Bengaluru 46
Denver 41
Genoa 41
Johannesburg 40
Hillsboro 39
Belo Horizonte 38
Figino 38
Stockholm 35
Atlanta 33
Casablanca 33
Quito 33
San Francisco 33
Venice 33
Biên Hòa 32
Tianjin 32
Baghdad 31
Catania 31
Miano 31
Abuja 29
Redwood City 29
Curitiba 28
Amsterdam 27
Manchester 27
Totale 35.017
Salva come PNG Salva come JPEG
Nome #
Behçet's syndrome patients exhibit specific microbiome signature. 515
An approach to differential diagnosis of antiphospholipid antibody syndrome and related conditions. 358
Long-term efficacy and safety of anakinra in a patient with Behçet's disease and concomitant tuberculosis infection 337
Central vein sign differentiates MS from CNS inflammatory vasculopathies. 322
Pathogenesis and potential therapeutic targets in systemic lupus erythematosus: from bench to bedside 313
A biochemical approach to detect oxidative stress in infertile women undergoing assisted reproductive technology procedures 310
Adalimumab effectively controls both anterior and posterior noninfectious uveitis associated with systemic inflammatory diseases: focus on Behçet’s syndrome 306
Preliminary data revealing efficacy of Streptococcus salivarius K12 (SSK12) in Periodic Fever, Aphthous stomatitis, Pharyngitis, and cervical Adenitis (PFAPA) syndrome: A multicenter study from the AIDA Network PFAPA syndrome registry 304
SIRT1 activity is decreased in lesional psoriatic skin 296
Sirt1 Protects against Oxidative Stress-Induced Apoptosis in Fibroblasts from Psoriatic Patients: A New Insight into the Pathogenetic Mechanisms of Psoriasis 280
Neutrophil Activation Promotes Fibrinogen Oxidation and Thrombus Formation in Behçet’s Disease 280
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) Study 272
Diagnostic criteria for adult-onset periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) syndrome 269
A Snapshot on the On-Label and Off-Label Use of the Interleukin-1 Inhibitors in Italy among Rheumatologists and Pediatric Rheumatologists: A Nationwide Multi-Center Retrospective Observational Study. 267
Repeated low-dose courses of rituximab in SLE-associated antiphospholipid syndrome: Data from a tertiary dedicated centre 263
A large-scale genetic analysis reveals an autoimmune origin of idiopathic retroperitoneal fibrosis 262
Adalimumab Accounts for Long-Term Control of Noninfectious Uveitis Also in the Absence of Concomitant DMARD Treatment: A Multicenter Retrospective Study 260
The different functional distribution of "not effector" T cells (Treg/Tnull) in colorectal cancer 259
ANCA-associated vasculitis in childhood: Recent advances 253
Digital ulcers secondary to Sneddon's syndrome successfully treated with Bosentan: not only useful in Systemic Sclerosis 252
Benralizumab for eosinophilic granulomatosis with polyangiitis: a retrospective, multicentre, cohort study 250
Anifrolumab In Refractory Systemic Lupus Erythematosus: A Real-Life, Multicenter Study 235
Polypharmacy in older people: lessons from 10 years of experience with the REPOSI register 232
Brief Report: Rituximab for the treatment of adult-onset IgA vasculitis (Henoch-Schönlein purpura) 231
Thrombosis in Autoimmune Diseases: A Role for Immunosuppressive Treatments? 226
Intravenous immunoglobulin for the secondary prevention of stillbirth in obstetric antiphospholipid syndrome: A case series and systematic review of literature 225
First report of FIP1L1-PDGFR alpha-positive eosinophilic granulomatosis with polyangiitis 224
A Report of 2 Cases of Kidney Involvement in ADA2 Deficiency: Different Disease Phenotypes and the Tissue Response to Type I Interferon 221
Subclinical atherosclerosis and history of cardiovascular events in Italian patients with rheumatoid arthritis 221
The link “Cancer and autoimmune diseases” in the light of microbiota: Evidence of a potential culprit 216
Thrombosis in vasculitis: from pathogenesis to treatment 214
Behcet's Syndrome as a Model of Thrombo-Inflammation: The Role of Neutrophils 211
Cardiac involvement in Churg Strauss syndrome: an update on cardiological manifestations 211
Intravenous immunoglobulin therapy: a snapshot for the internist. 210
Erythrocyte membrane fluidity alterations in sudden sensorineural hearing loss patients: The role of oxidative stress 210
Implementation of the Frailty Index in hospitalized older patients: Results from the REPOSI register 209
A new cytofluorimetric approach to evaluate the circulating microparticles in subjects with antiphospholipid antibodies 207
Cytotoxic Th1 and Th17 cells infiltrate the intestinal mucosa of Behcet patients and exhibit high levels of TNF-α in early phases of the disease 206
Role of polymorphonucleates in the pathogenesis of systemic juvenile idiopathic arthritis and Still's disease: A proof of concept study 206
Behçet's syndrome as a tool to dissect the mechanisms of thrombo-inflammation: clinical and pathogenetic aspects 206
Comparison of Early vs. Delayed Anakinra Treatment in Patients With Adult Onset Still's Disease and Effect on Clinical and Laboratory Outcomes 205
Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study 204
Defining aging phenotypes and related outcomes: Clues to recognize frailty in hospitalized older patients 203
Pharmacological prevention of venous thromboembolism in orthopaedic surgery 201
Stem-Cell-Derived Circulating Progenitors Dysfunction in Behçet's Syndrome Patients Correlates With Oxidative Stress 201
Alveolar haemorrhage in ANCA-associated vasculitis: Long-term outcome and mortality predictors 201
Long-term effectiveness and safety of secukinumab for treatment of refractory mucosal and articular Behçet's phenotype: A multicentre study 201
A unique circulating miRNA profile highlights thrombo-inflammation in Behçet's syndrome 201
Anakinra for the Treatment of COVID-19-Associated Pericarditis: A Case Report 200
Early Disease and Low Baseline Damage as Predictors of Response to Belimumab in Patients With Systemic Lupus Erythematosus in a Real-Life Setting 198
Prevalence and clinical associations of ultrasound-confirmed enthesitis in systemic lupus erythematosus 197
The Presence of Uveitis Is Associated With a Sustained Response to the Interleukin (IL)-1 Inhibitors Anakinra and Canakinumab in Behçet's Disease 195
A Genome-wide Association Study Identifies Risk Alleles in Plasminogen and P4HA2 Associated with Giant Cell Arteritis 195
Thrombosis in inflammatory bowel diseases: What's the link? 194
Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients 194
Belimumab reduces antiphospholipid antibodies in SLE patients independently of hydroxychloroquine treatment 194
Blood Leukocyte ROS Production Reflects Seminal Fluid Oxidative Stress and Spermatozoa Dysfunction in Idiopathic Infertile Men 192
Systemic lupus erythematosus: immunopathogenesis and novel therapeutic targets 192
Mepolizumab for Eosinophilic Granulomatosis with Polyangiitis (EGPA): a European multicenter observational study 192
Cardiac involvement in eosinophilic granulomatosis with polyangiitis (formerly Churg-Strauss syndrome): Prospective evaluation at a tertiary referral centre 192
A case of lichenoid drug eruption associated with subcutaneous immunoglobulin therapy. 191
I farmaci biologici 191
Response to interleukin-1 inhibitors in 140 Italian patients with adult-onset still's disease: A multicentre retrospective observational study 189
Mortality rate and risk factors for gastrointestinal bleeding in elderly patients 189
Comparison of treatments for the prevention of fetal growth restriction in obstetric antiphospholipid syndrome: a systematic review and network meta-analysis 189
Adalimumab-Based Treatment Versus Disease-Modifying Antirheumatic Drugs for Venous Thrombosis in Behçet's Syndrome: A Retrospective Study of Seventy Patients With Vascular Involvement 189
Efficacy and safety of tocilizumab in adult-onset Still's disease: Real-life experience from the international AIDA registry 188
Interleukin-17/Interleukin-21 and Interferon-g producing T cells specific for β2 Glycoprotein I in atherosclerosis inflammation of systemic lupus erythematosus patients with antiphospholipid syndrome 188
Cumulative retention rate of adalimumab in patients with Behçet's disease-related uveitis: a four-year follow-up study 186
OP0148 MEPOLIZUMAB FOR EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (EGPA): A RETROSPECTIVE REAL-WORLD EUROPEAN STUDY ON 142 PATIENTS 186
Rapid desensitization to anakinra-related delayed reaction: Need for a standardized protocol 185
Nailfold Capillaroscopy Characteristics of Antisynthetase Syndrome and Possible Clinical Associations: Results of a Multicenter International Study 185
Antihypertensive treatment changes and related clinical outcomes in older hospitalized patients 184
Pathogenesis of Behcet Syndrome 184
Serum IgG2 antibody multicomposition in systemic lupus erythematosus and lupus nephritis (Part 1): cross-sectional analysis 183
Durable renal response and safety with add-on belimumab in patients with lupus nephritis in real-life setting (BeRLiSS-LN). Results from a large, nationwide, multicentric cohort 183
Redox status alterations during the competitive season in élite soccer players: focus on peripheral leukocyte-derived ROS 182
Clinical and Prognostic Significance of Serum IgG4 in Chronic Periaortitis. An Analysis of 113 Patients 182
Butyrate Rich Diets Improve Redox Status and Fibrin Lysis in Behçet's Syndrome 181
Influence of gender on Behçet's Disease phenotype and irreversible organ damage: Data from the International AIDA Network Behçet's Disease Registry 180
Cutaneous sarcoidosis during rituximab treatment for microscopic polyangiitis: An uncommon adverse effect? 180
β2 Glycoprotein I Recognition Drives Th1 Inflammation in Atherosclerotic Plaques of Patients with Primary Antiphospholipid Syndrome 180
Eosinophilic Granulomatosis With Polyangiitis: Dissecting the Pathophysiology 180
Efficacy and safety of infliximab or adalimumab in severe mucocutaneous Behçet's syndrome refractory to traditional immunosuppressants: a 6-month, multicentre, randomised controlled, prospective, parallel group, single-blind trial 179
Susceptibility weighted MRI can help differentiating pathogenesis of white matter lesions in MS and CNS inflammatory vasculopathies. 179
Secukinumab reduces plasma oxidative stress in psoriasis: A case-based experience 179
Genome-wide association study of eosinophilic granulomatosis with polyangiitis reveals genomic loci stratified by ANCA status 178
Long-term retention rate of anakinra in adult onset Still’s disease and predictive factors for treatment response 178
Impact of cardiovascular and immunologic variables on subclinical carotid atherosclerosis in subjects with anti-phospholipid antibodies 178
Prognostic Factors and Long-Term Outcome with ANCA-Associated Kidney Vasculitis in Childhood 177
Lobular panniculitis with small vessel vasculitis associated with ulcerative colitis. 177
MRI evaluation of the "central vein sign" in brain white matter lesions of multiple sclerosis and systemic autoimmune diseases. 176
An insight into giant cell arteritis pathogenesis: Evidence for oxidative stress and sirt1 downregulation 175
135. ATHERO-THROMBOTIC AND VENOUS EVENTS (AVTE) IN EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (EGPA): A MULTICENTRE STUDY OF 573 ITALIAN PATIENTS 175
Validation of the Italian version of the ANCA-associated vasculitis patient-reported outcome (AAV-PRO) questionnaire 174
The Autoinflammatory Diseases Alliance Registry of monogenic autoinflammatory diseases 174
Short article: Safety of targeted prophylaxis strategy in patients with resolved hepatitis B virus infection receiving rituximab for immune-mediated diseases 174
The Shc family protein adaptor, Rai, acts as a negative regulator of Th17 and Th1 cell development. 174
CSF/serum matrix metallopeptidase‐9 ratio discriminates neuro Behçet from multiple sclerosis 174
Circulating miRNome profiling data in Behçet's syndrome 174
Totale 21.551
Salva come PNG Salva come JPEG
Categoria #
all - tutte 173.216
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 173.216
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.903 0 75 231 74 50 130 50 215 125 82 281 590
2022/20235.057 450 1.102 267 219 219 871 681 266 496 63 179 244
2023/20242.502 92 172 342 162 162 352 128 481 77 235 154 145
2024/202516.288 598 1.722 896 2.595 4.267 2.014 458 786 826 595 718 813
2025/202620.909 2.022 2.704 2.154 2.409 2.037 752 2.191 942 1.157 1.273 702 2.566
2026/20271.286 748 538 0 0 0 0 0 0 0 0 0 0
Totale 55.321